Phase I/II and pharmacokinetic study of combination chemotherapy with S-1 and oxaliplatin in patients with previously untreated metastatic or recurrent gastric cancer

被引:0
|
作者
Park, I. [1 ]
Lee, J. [1 ]
Ryu, M. [1 ]
Chang, H. [1 ]
Kim, T. [1 ]
Sym, S. [1 ]
Lee, S. [1 ]
Jang, G. [1 ]
Bae, K. [1 ]
Kang, Y. [1 ]
机构
[1] Asan Med Ctr, Seoul, South Korea
关键词
D O I
10.1200/jco.2008.26.15_suppl.4557
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4557
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Phase I Dose-finding Study of Epirubicin, Oxaliplatin and S-1 (EOS) in Patients With Previously Untreated Advanced Gastric Cancer (AGC)
    Sym, S. J.
    Hong, J.
    Jung, M.
    Park, J.
    Cho, E. K.
    Lee, W. K.
    Chung, M.
    Park, Y. H.
    Lee, J. H.
    Shin, D. B.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S466 - S466
  • [42] Phase I study of S-1 and biweekly docetaxel combination chemotherapy for advanced and recurrent gastric cancer
    Takahashi, I
    Emi, Y
    Kakeji, Y
    Tokunaga, E
    Ushiro, S
    Oki, E
    Watanabe, M
    Baba, H
    Maehara, Y
    ONCOLOGY REPORTS, 2006, 15 (04) : 849 - 854
  • [43] Phase I clinical and pharmacokinetic/pharmacogenetic study of a triplet regimen of S-1/irinotecan/oxaliplatin in patients with metastatic colorectal or gastric cancer
    Sook Ryun Park
    Yong Sang Hong
    Hyeong-Seok Lim
    Moon-Woo Seong
    Sun-Young Kong
    Sun Young Kim
    Young-Iee Park
    Kyung Hae Jung
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 953 - 964
  • [44] Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer
    Sym, Sun Jin
    Ryu, Min-Hee
    Kang, Hye Jin
    Lee, Sung Sook
    Chang, Heung-Moon
    Lee, Jae Lyun
    Kim, Tae Won
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    Kang, Yoon-Koo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (02) : 373 - 380
  • [45] Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer
    Sun Jin Sym
    Min-Hee Ryu
    Hye Jin Kang
    Sung Sook Lee
    Heung-Moon Chang
    Jae Lyun Lee
    Tae Won Kim
    Jeong Hwan Yook
    Sung Tae Oh
    Byung Sik Kim
    Yoon-Koo Kang
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 373 - 380
  • [46] Phase I clinical and pharmacokinetic/pharmacogenetic study of a triplet regimen of S-1/irinotecan/oxaliplatin in patients with metastatic colorectal or gastric cancer
    Park, Sook Ryun
    Hong, Yong Sang
    Lim, Hyeong-Seok
    Seong, Moon-Woo
    Kong, Sun-Young
    Kim, Sun Young
    Park, Young-Iee
    Jung, Kyung Hae
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (05) : 953 - 964
  • [47] A phase II study of irinotecan and docetaxel combination chemotherapy for patients with previously treated metastatic or recurrent advanced gastric cancer
    Sun Jin Sym
    Heung Moon Chang
    Hye Jin Kang
    Sung Sook Lee
    Min-Hee Ryu
    Jae-Lyun Lee
    Tae-Won Kim
    Jeong Hwan Yook
    Sung Tae Oh
    Byung Sik Kim
    Yoon-Koo Kang
    Cancer Chemotherapy and Pharmacology, 2008, 63 : 1 - 8
  • [48] A phase II study of irinotecan and docetaxel combination chemotherapy for patients with previously treated metastatic or recurrent advanced gastric cancer
    Sym, Sun Jin
    Chang, Heung Moon
    Kang, Hye Jin
    Lee, Sung Sook
    Ryu, Min-Hee
    Lee, Jae-Lyun
    Kim, Tae-Won
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    Kang, Yoon-Koo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 63 (01) : 1 - 8
  • [49] Phase II study of a combination of S-1 and paclitaxel in patients with unresectable or metastatic gastric cancer
    Narahara, Hiroyuki
    Fujitani, Kazumasa
    Takiuchi, Hiroya
    Sugimoto, Naotoshi
    Inoue, Kentaro
    Uedo, Noriya
    Tsukuma, Hideaki
    Tsujinaka, Toshimasa
    Furukawa, Hiroshi
    Taguchi, Tetsuo
    ONCOLOGY, 2008, 74 (1-2) : 37 - 41
  • [50] S-1 plus oxaliplatin vs. S-1 as first-line treatment in patients with previously untreated advanced gastric cancer: a randomized phase II study
    Lu, Yiming
    Liu, Zanchao
    Zhang, Jun
    JOURNAL OF CHEMOTHERAPY, 2014, 26 (03) : 159 - 164